Seeing Is Believing

Currently out of the existing stock ratings of Yaron Werber, 148 are a BUY (75.51%), 47 are a HOLD (23.98%), 1 are a SELL (0.51%).
Analyst Yaron Werber, currently employed at TD COWEN, carries an average stock price target met ratio of 63.69% that have a potential upside of 23.33% achieved within 338 days.
Yaron Werber’s has documented 385 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on GMAB, Genmab AS.
Analyst best performing recommendations are on GMAB (GENMAB AS).
The best stock recommendation documented was for ARGX (ARGENX NV ADR) at 7/17/2023. The price target of $533 was fulfilled within 3 days with a profit of $48.57 (10.03%) receiving and performance score of 33.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-May-2019
$480
$40.74 (9.27%)
$450
6 days ago
(22-Oct-2026)
40/42 (95.24%)
$40.74 (9.27%)
705
Hold Since 21-Feb-2026
$400
$-39.26 (-8.94%)
$380
8 days ago
(20-Oct-2026)
2/4 (50%)
$-38.34 (-8.75%)
27
Hold Since 11-Oct-2026
$415
$-24.26 (-5.52%)
$450
17 days ago
(11-Oct-2026)
33/35 (94.29%)
$0.13 (0.03%)
543
Hold Since 09-Jan-2025
$430
$-9.26 (-2.11%)
$435
17 days ago
(11-Oct-2026)
21/22 (95.45%)
$15.13 (3.65%)
343
Buy Since 25-Jan-2026
$470
$30.74 (7.00%)
$430
17 days ago
(11-Oct-2026)
39/40 (97.5%)
$55.13 (13.29%)
755
Which stock is Yaron Werber most bullish on?
Which stock is Yaron Werber most reserved on?
What Year was the first public recommendation made by Yaron Werber?